PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Protalix BioTherapeutics, Inc.
Filed: October 5, 2018
Period of Report: December 13, 2018
Accession Number: 0001144204-18-052765

View Document ↗ View on SEC.gov ↗